Current and historical daily PE Ratio for KMDA (
Kamada Ltd
) from 2013 to Apr 29 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kamada stock (KMDA) PE ratio as of Apr 29 2024 is 35.2.
More Details
Kamada Ltd (KMDA) PE Ratio (TTM) Chart
Kamada Ltd (KMDA) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1217
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Kamada PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-30 | 35.2 | 2024-02-23 | 41.0 |
| 2024-04-26 | 34.3 | 2024-02-22 | 41.5 |
| 2024-04-25 | 34.7 | 2024-02-21 | 40.1 |
| 2024-04-24 | 34.5 | 2024-02-20 | 40.4 |
| 2024-04-23 | 33.9 | 2024-02-16 | 40.9 |
| 2024-04-22 | 34.0 | 2024-02-15 | 40.9 |
| 2024-04-19 | 33.7 | 2024-02-14 | 40.1 |
| 2024-04-18 | 34.0 | 2024-02-13 | 39.4 |
| 2024-04-17 | 33.9 | 2024-02-12 | 40.1 |
| 2024-04-16 | 32.7 | 2024-02-09 | 39.9 |
| 2024-04-15 | 34.1 | 2024-02-08 | 39.9 |
| 2024-04-12 | 34.3 | 2024-02-07 | 39.3 |
| 2024-04-11 | 34.7 | 2024-02-06 | 38.5 |
| 2024-04-10 | 35.1 | 2024-02-05 | 37.3 |
| 2024-04-09 | 35.3 | 2024-02-02 | 38.1 |
| 2024-04-08 | 36.1 | 2024-02-01 | 38.7 |
| 2024-04-05 | 35.9 | 2024-01-31 | 38.2 |
| 2024-04-04 | 35.5 | 2024-01-30 | 37.4 |
| 2024-04-03 | 37.3 | 2024-01-29 | 37.7 |
| 2024-04-02 | 37.1 | 2024-01-26 | 38.3 |
| 2024-04-01 | 37.4 | 2024-01-25 | 37.6 |
| 2024-03-28 | 37.4 | 2024-01-24 | 38.6 |
| 2024-03-27 | 37.3 | 2024-01-23 | 37.5 |
| 2024-03-26 | 37.3 | 2024-01-22 | 38.9 |
| 2024-03-25 | 38.2 | 2024-01-19 | 39.1 |
| 2024-03-22 | 38.2 | 2024-01-18 | 39.2 |
| 2024-03-21 | 38.7 | 2024-01-17 | 37.4 |
| 2024-03-20 | 39.1 | 2024-01-16 | 37.7 |
| 2024-03-19 | 38.3 | 2024-01-12 | 39.3 |
| 2024-03-18 | 39.1 | 2024-01-11 | 39.6 |
| 2024-03-15 | 37.3 | 2024-01-10 | 40.0 |
| 2024-03-14 | 37.2 | 2024-01-09 | 40.2 |
| 2024-03-13 | 38.1 | 2024-01-08 | 40.6 |
| 2024-03-12 | 38.6 | 2024-01-05 | 39.7 |
| 2024-03-11 | 38.1 | 2024-01-04 | 41.1 |
| 2024-03-08 | 40.3 | 2024-01-03 | 40.7 |
| 2024-03-07 | 41.3 | 2024-01-02 | 41.1 |
| 2024-03-06 | 40.3 | 2023-12-29 | 40.8 |
| 2024-03-05 | 42.5 | 2023-12-28 | 41.3 |
| 2024-03-04 | 42.8 | 2023-12-27 | 47.9 |
| 2024-03-01 | 42.5 | 2023-12-26 | 46.8 |
| 2024-02-29 | 42.0 | 2023-12-22 | 46.8 |
| 2024-02-28 | 41.7 | 2023-12-21 | 45.9 |
| 2024-02-27 | 42.7 | 2023-12-20 | 45.9 |
| 2024-02-26 | 40.8 | 2023-12-19 | 46.1 |
Kamada Ltd (KMDA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Kamada Ltd
NAICS : 325412
SIC : 2834
ISIN : IL0010941198
Compare
Compare
Traded in other countries / regions
KMDA.IsraelKMDA.USA IPO Date
2013-05-31Description
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers